• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺多形性小叶原位癌的管理难点。

Challenges in the management of pleomorphic lobular carcinoma in situ of the breast.

机构信息

Guy's Hospital, Guy's & St Thomas NHS Foundation Trust, Great Maze Pond, London SE1 9RT, United Kingdom.

Guy's Hospital, Guy's & St Thomas NHS Foundation Trust, Great Maze Pond, London SE1 9RT, United Kingdom; Section of Research Oncology, Division of Cancer Studies, King's College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, United Kingdom.

出版信息

Breast. 2013 Apr;22(2):194-196. doi: 10.1016/j.breast.2013.01.003. Epub 2013 Jan 26.

DOI:10.1016/j.breast.2013.01.003
PMID:23357705
Abstract

BACKGROUND

Pleomorphic Lobular Carcinoma in Situ (PLCIS) is a pathological variant of Lobular Carcinoma in Situ (LCIS) with distinct features. Since first described over a decade ago there are only few papers published about this condition.

METHODS

Medline and Pubmed based literature overview was done with the aim of describing the different histopathological, radiological and clinical features of this pathological entity to highlight the different clinicopathological presentations and modalities of treatment described.

RESULTS

PLCIS has different biological features when compared to LCIS. It is more likely to be associated with invasive disease and the immuno-histochemical profile shows it is less likely to be ER and PR positive with higher positivity of HER2, Ki-67and p53. It has been suggested that PLCIS should be treated more aggressively than LCIS and surgically excised in similar fashion to DCIS.

CONCLUSION

PLCIS is a more aggressive variant of LCIS that needs to be managed differently. Surgical excision with clear margins is advised. Further adjuvant treatments have been described in the literature with little evidence to support their use.

摘要

背景

多形性小叶原位癌(PLCIS)是小叶原位癌(LCIS)的一种具有独特特征的病理变异。自十多年前首次描述以来,仅有少数几篇关于这种情况的论文发表。

方法

通过 Medline 和 Pubmed 进行文献综述,旨在描述这种病理实体的不同组织病理学、影像学和临床特征,以突出描述的不同临床病理表现和治疗方式。

结果

与 LCIS 相比,PLCIS 具有不同的生物学特征。它更有可能与浸润性疾病相关,免疫组织化学特征显示其 ER 和 PR 阳性率较低,而 HER2、Ki-67 和 p53 阳性率较高。有人认为,PLCIS 的治疗应该比 LCIS 更具侵袭性,并且应该以类似于 DCIS 的方式进行手术切除。

结论

PLCIS 是 LCIS 的一种侵袭性更强的变异型,需要采用不同的治疗方法。建议进行有明确切缘的手术切除。文献中还描述了其他辅助治疗方法,但几乎没有证据支持其使用。

相似文献

1
Challenges in the management of pleomorphic lobular carcinoma in situ of the breast.乳腺多形性小叶原位癌的管理难点。
Breast. 2013 Apr;22(2):194-196. doi: 10.1016/j.breast.2013.01.003. Epub 2013 Jan 26.
2
Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis.乳腺多形性小叶原位癌(PLCIS)的筛检:核心活检诊断后并发浸润性恶性肿瘤的风险。
Histopathology. 2010 Sep;57(3):472-8. doi: 10.1111/j.1365-2559.2010.03634.x. Epub 2010 Aug 19.
3
Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.原位多形性小叶癌:放射学-病理学特征及临床处理
Ann Surg Oncol. 2015 Dec;22(13):4263-9. doi: 10.1245/s10434-015-4552-x. Epub 2015 Apr 17.
4
Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.乳腺粗针穿刺活检中的多形性小叶原位癌(PLCIS):临床意义及免疫表型
Am J Surg Pathol. 2008 Nov;32(11):1721-6. doi: 10.1097/PAS.0b013e31817dc3a6.
5
Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast.乳腺原位多形性小叶癌的特征及临床结局
Breast J. 2018 Jan;24(1):66-69. doi: 10.1111/tbj.12843. Epub 2017 Sep 19.
6
Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.乳腺原位多形性小叶癌:单机构临床随访及集中病理检查经验
Breast Cancer Res Treat. 2017 Sep;165(2):411-420. doi: 10.1007/s10549-017-4334-1. Epub 2017 Jun 13.
7
Is there a low-grade precursor pathway in breast cancer?乳腺癌是否存在低度恶性前体途径?
Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.
8
Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.乳腺芯中原位小叶癌的变异型:误诊的可能性、手术切除时的升级率及实际影响。
Arch Pathol Lab Med. 2010 Jul;134(7):1024-8. doi: 10.5858/2009-0300-OA.1.
9
Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.多形性 LCIS 我们了解多少?一项英国多中心的多形性小叶原位癌研究。
Breast. 2018 Apr;38:120-124. doi: 10.1016/j.breast.2017.12.011. Epub 2018 Jan 5.
10
The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.乳腺小叶原位癌和不典型小叶增生的意义。
Ann Surg Oncol. 2012 Dec;19(13):4124-8. doi: 10.1245/s10434-012-2538-5. Epub 2012 Jul 31.

引用本文的文献

1
Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.现代乳腺癌手术:第 1 次中东部欧洲乳腺癌专业共识声明。
Pathol Oncol Res. 2022 Jun 15;28:1610377. doi: 10.3389/pore.2022.1610377. eCollection 2022.
2
American Registry of Pathology Expert Opinions: The Spectrum of Lobular Carcinoma in Situ: Diagnostic Features and Clinical Implications.美国病理学专家意见登记处:小叶原位癌的范围:诊断特征和临床意义。
Ann Diagn Pathol. 2020 Apr;45:151481. doi: 10.1016/j.anndiagpath.2020.151481. Epub 2020 Feb 15.
3
Thymic stromal lymphopoietin blocks early stages of breast carcinogenesis.
胸腺基质淋巴细胞生成素可阻断乳腺癌发生的早期阶段。
J Clin Invest. 2016 Apr 1;126(4):1458-70. doi: 10.1172/JCI83724. Epub 2016 Feb 29.
4
UK national survey of management of breast lobular carcinoma in situ.英国乳腺小叶原位癌管理全国性调查。
Ann R Coll Surg Engl. 2015 Nov;97(8):574-7. doi: 10.1308/rcsann.2015.0037.
5
Underestimation rate of lobular intraepithelial neoplasia in vacuum-assisted breast biopsy.真空辅助乳腺活检中小叶原位癌的低估率
Eur Radiol. 2014 Jul;24(7):1651-8. doi: 10.1007/s00330-014-3132-y. Epub 2014 Apr 18.
6
[Lobular neoplasms and invasive lobular breast cancer].[小叶性肿瘤与浸润性小叶癌]
Pathologe. 2014 Feb;35(1):45-53. doi: 10.1007/s00292-013-1840-8.